Publications by authors named "Hani Al-Terki"
Background: Ultrasound-assisted thrombolysis (USAT) and large-bore-thrombectomy (LBT) are under investigation for the treatment of intermediate-high and high-risk pulmonary embolisms (PE). Comparative studies investigating both devices are scarce.
Aims: This study aimed to compare the safety and efficacy of the two most frequently used devices for treatment of acute PE.
Background: Ultrasound-accelerated thrombolysis (USAT) is a safe and effective treatment for patients with intermediate-high-risk pulmonary embolism (PE). In all studies investigating USAT in the setting of PE, the recombinant tissue-plasminogen activator (rt-PA) alteplase or actilyse was used. Currently, there is a shortage of alteplase (Alteplase, Boehringer Ingelheim) in Europe.
View Article and Find Full Text PDFUltrasound-accelerated thrombolysis (USAT) is an advanced interventional therapy for patients with intermediate-high-risk pulmonary embolism (PE) who deteriorated on anticoagulation or for high-risk patients for whom systemic thrombolysis is contraindicated. The aim of this study is to investigate the safety and efficacy of this therapy with a focus on the improvement of vital signs and laboratory parameters. Seventy-nine patients with intermediate-high-risk PE were treated with USAT from August 2020 to November 2022.
View Article and Find Full Text PDFBackground: Pulmonary embolism (PE) is a common cardiovascular disease. Elderly patients with acute PE have very high mortality rates. Data concerning the safety and effectiveness of ultrasound-accelerated thrombolysis (USAT) in this age group are lacking.
View Article and Find Full Text PDFInfective endocarditis of a left atrial appendage closure device: a case report and literature review.
Eur Heart J Case Rep
November 2022
Article Synopsis
- Advances in interventional cardiology have led to increased use of cardiac devices, resulting in more cases of device-associated endocarditis, a serious condition with complex treatment challenges.
- The case of an 83-year-old woman illustrates the risks, as she developed endocarditis linked to her left atrial appendage closure device 20 months post-procedure, leading to her eventual death despite antibiotic treatment.
- The report highlights the rarity of LAA closure device-associated endocarditis but notes that as these devices become more common, healthcare professionals should anticipate an increase in such infections, emphasizing the need for accurate diagnostic methods like transoesophageal echocardiography.
Background: During the last years, several transcatheter aortic heart valves entered the clinical market and are commercially available. The prostheses differ regarding several technical and functional aspects. However, little is known regarding head-to-head comparative data of the ACURATE neo and the PORTICO valve prostheses.
View Article and Find Full Text PDFAims: Both surgical aortic valve replacement (SAVR) and transcatheter aortic valve implantation (TAVI) are established options to treat aortic valve stenosis. We present the outcome of the complete cohort of all patients undergoing SAVR or TAVI in Germany during the calendar year 2019.
Methods And Results: Data concerning all isolated aortic valve procedures performed in Germany in 2019 were retrieved from the mandatory nationwide quality control program: 22,973 transvascular (TV)-TAVI procedures, 7905 isolated SAVR (iSAVR), and 1413 transapical (TA)-TAVI.